Faculty Affiliations and Disclosures



Andrew D. Krystal, MD, MS
Andrew D. Krystal, MD, MS, is currently professor of psychiatry and behavioral sciences at the Duke University School of Medicine. There, he directs the Sleep Research Laboratory, the Insomnia Clinic, and the Quantitative EEG Laboratory. He attended the Massachusetts Institute of Technology where he completed Bachelor's and Master's Degrees in biomedical engineering. He earned his doctorate in medicine from Duke University in 1987. He subsequently completed psychiatry residency training at Duke along with fellowships in clinical neurophysiology and clinical research methodology. He is board certified in psychiatry, sleep medicine, and clinical neurophysiology. Dr. Krystal currently serves as an associate editor of the journal Sleep and is the chairman of the research committee of the Sleep Research Society. His primary areas of clinical work are in sleep disorders, EEG, and mood disorders. His primary research is related to the pathophysiology and treatment of sleep disorders and mood disorders.  

Disclosures:
Dr. Krystal is a consultant to Abbott, Actelion, Arena, Astellas, AstraZeneca, Axiom, Bristol-Myers Squibb, Cephalon, CHDI, Eli Lilly, GlaxoSmithKline, Jazz, Johnson and Johnson, King, Kingsdown, Merck, Neurocrine, Neurogen, Neuronetics, Novartis, Organon, Ortho-McNeil Janssen, Pfizer, Research Triangle Institute, Respironics, Roche, sanofi-aventis, Sepracor, Somaxon, Takeda, and Transcept; and receives grant/research support from Astellas, Cephalon, Evotec, GlaxoSmithKline, Merck, the National Institutes of Health, Neurocrine, Neurogen, Neuronetics, Pfizer, Respironics, sanofi-aventis, Sepracor, Somaxon, Takeda, and Transcept.

John W. Winkelman, MD, PhD
John W. Winkelman, MD, PhD, is associate professor of psychiatry at Harvard Medical School and medical director of the Sleep Health Center of Brigham and Women's Hospital in Boston, Massachusetts. He received his doctorate in medicine from Harvard Medical School and his PhD in psychobiology from Harvard University. He also completed both a residency in psychiatry and a fellowship in sleep medicine at Massachusetts General Hospital. Dr. Winkelman has published extensively in the areas of restless legs syndrome (RLS) and periodic limb movements of sleep, insomnia, parasomnias, and the effects of medications on sleep. He has developed and directed multiple post-graduate medical education courses in the area of sleep disorders nationally and internationally.
Dr. Winkelman is immediate past chair of the nosology committee of the American Academy of Sleep Medicine, is currently chair of the American Academy of Neurology practice parameter committee for the treatment of RLS, is an associate editor for Sleep and serves on the editorial boards of Sleep Medicine, CNS Drugs, and the International Journal of Sleep Disorders.

Disclosures:
Dr. Winkelman is a consultant to and receives honoraria from sanofi-aventis and Sepracor.

W. Vaughn McCall, MD, MS
W. Vaughn McCall, MD, MS, is currently professor and chairman of the Department of Psychiatry and Behavioral Medicine at the Wake Forest University School of Medicine.  He completed his medical degree and postgraduate psychiatric training at Duke University. He completed a Masters degree in epidemiology from Wake Forest University. He is board certified in general psychiatry, geriatric psychiatry, and sleep disorders medicine. His research interests include depression, electroconvulsive therapy, quality of life, and insomnia. His research has been continuously funded by the National Institute of Mental Health since 1995, and he is author of more than 120 peer-reviewed journal articles. He is editor of the Journal of ECT, past president of the Association for Convulsive Therapy, and a prior director of the board of the American Academy of Sleep Medicine.  

Disclosures:
Dr. McCall receives research support and honoraria from sanofi-aventis and Sepracor.